310 related articles for article (PubMed ID: 25254489)
1. Do intravenous N-acetylcysteine and sodium bicarbonate prevent high osmolal contrast-induced acute kidney injury? A randomized controlled trial.
Inda-Filho AJ; Caixeta A; Manggini M; Schor N
PLoS One; 2014; 9(9):e107602. PubMed ID: 25254489
[TBL] [Abstract][Full Text] [Related]
2. Prevention of contrast-induced acute kidney injury in patients with stable chronic renal disease undergoing elective percutaneous coronary and peripheral interventions: randomized comparison of two preventive strategies.
Hafiz AM; Jan MF; Mori N; Shaikh F; Wallach J; Bajwa T; Allaqaband S
Catheter Cardiovasc Interv; 2012 May; 79(6):929-37. PubMed ID: 21542114
[TBL] [Abstract][Full Text] [Related]
3. Prevention of acute renal failure post-contrast imaging in cardiology: a randomized study.
Alessandri N; Lanzi L; Garante CM; Tersigni F; Sergiacomi R; Petrassi M; Di Matteo A; Tufano F
Eur Rev Med Pharmacol Sci; 2013 Feb; 17 Suppl 1():13-21. PubMed ID: 23436661
[TBL] [Abstract][Full Text] [Related]
4. Comparison of combination therapy of high-dose oral N-acetylcysteine and intravenous sodium bicarbonate hydration with individual therapies in the reduction of Contrast-induced Nephropathy during Cardiac Catheterisation and Percutaneous Coronary Intervention (CONTRAST): A multi-centre, randomised, controlled trial.
Chong E; Poh KK; Lu Q; Zhang JJ; Tan N; Hou XM; Ong HY; Azan A; Chen SL; Chen JY; Ali RM; Fang WY; Lau TW; Tan HC
Int J Cardiol; 2015 Dec; 201():237-42. PubMed ID: 26301645
[TBL] [Abstract][Full Text] [Related]
5. Usefulness of N-acetylcysteine or ascorbic acid versus placebo to prevent contrast-induced acute kidney injury in patients undergoing elective cardiac catheterization: a single-center, prospective, randomized, double-blind, placebo-controlled trial.
Brueck M; Cengiz H; Hoeltgen R; Wieczorek M; Boedeker RH; Scheibelhut C; Boening A
J Invasive Cardiol; 2013 Jun; 25(6):276-83. PubMed ID: 23735352
[TBL] [Abstract][Full Text] [Related]
6. N-acethyl-cysteine reduces the occurrence of contrast-induced acute kidney injury in patients with renal dysfunction: a single-center randomized controlled trial.
Heguilén RM; Liste AA; Payaslian M; Ortemberg MG; Albarracín LM; Bernasconi AR
Clin Exp Nephrol; 2013 Jun; 17(3):396-404. PubMed ID: 23138396
[TBL] [Abstract][Full Text] [Related]
7. Effects of hydration in contrast-induced acute kidney injury after primary angioplasty: a randomized, controlled trial.
Maioli M; Toso A; Leoncini M; Micheletti C; Bellandi F
Circ Cardiovasc Interv; 2011 Oct; 4(5):456-62. PubMed ID: 21972403
[TBL] [Abstract][Full Text] [Related]
8. Randomized trial of one-hour sodium bicarbonate vs standard periprocedural saline hydration in chronic kidney disease patients undergoing cardiovascular contrast procedures.
Kooiman J; de Vries JPM; Van der Heyden J; Sijpkens YWJ; van Dijkman PRM; Wever JJ; van Overhagen H; Vahl AC; Aarts N; Verberk-Jonkers IJAM; Brulez HFH; Hamming JF; van der Molen AJ; Cannegieter SC; Putter H; van den Hout WB; Kilicsoy I; Rabelink TJ; Huisman MV
PLoS One; 2018; 13(2):e0189372. PubMed ID: 29420536
[TBL] [Abstract][Full Text] [Related]
9. Sodium bicarbonate plus isotonic saline versus saline for prevention of contrast-induced nephropathy in patients undergoing coronary angiography: a randomized controlled trial.
Vasheghani-Farahani A; Sadigh G; Kassaian SE; Khatami SM; Fotouhi A; Razavi SA; Mansournia MA; Yamini-Sharif A; Amirzadegan A; Salarifar M; Sadeghian S; Davoodi G; Borumand MA; Esfehani FA; Darabian S
Am J Kidney Dis; 2009 Oct; 54(4):610-8. PubMed ID: 19619921
[TBL] [Abstract][Full Text] [Related]
10. Prevention of contrast-induced nephropathy with N-acetylcysteine or sodium bicarbonate in patients with ST-segment-myocardial infarction: a prospective, randomized, open-labeled trial.
Thayssen P; Lassen JF; Jensen SE; Hansen KN; Hansen HS; Christiansen EH; Junker A; Ravkilde J; Thuesen L; Veien KT; Jensen LO
Circ Cardiovasc Interv; 2014 Apr; 7(2):216-24. PubMed ID: 24714489
[TBL] [Abstract][Full Text] [Related]
11. N-acetylcysteine and sodium bicarbonate versus N-acetylcysteine and standard hydration for the prevention of radiocontrast-induced nephropathy following coronary angiography.
Schmidt P; Pang D; Nykamp D; Knowlton G; Jia H
Ann Pharmacother; 2007 Jan; 41(1):46-50. PubMed ID: 17190844
[TBL] [Abstract][Full Text] [Related]
12. Renal insufficiency following contrast media administration trial II (REMEDIAL II): RenalGuard system in high-risk patients for contrast-induced acute kidney injury: rationale and design.
Briguori C; Visconti G; Ricciardelli B; Condorelli G;
EuroIntervention; 2011 Apr; 6(9):1117-22, 7. PubMed ID: 21518686
[TBL] [Abstract][Full Text] [Related]
13. Sodium bicarbonate plus N-acetylcysteine prophylaxis: a meta-analysis.
Brown JR; Block CA; Malenka DJ; O'Connor GT; Schoolwerth AC; Thompson CA
JACC Cardiovasc Interv; 2009 Nov; 2(11):1116-24. PubMed ID: 19926054
[TBL] [Abstract][Full Text] [Related]
14. Kidney Biomarkers of Injury and Repair as Predictors of Contrast-Associated AKI: A Substudy of the PRESERVE Trial.
Parikh CR; Liu C; Mor MK; Palevsky PM; Kaufman JS; Thiessen Philbrook H; Weisbord SD
Am J Kidney Dis; 2020 Feb; 75(2):187-194. PubMed ID: 31547939
[TBL] [Abstract][Full Text] [Related]
15. Prevention of contrast-induced nephropathy in vascular patients undergoing angiography: a randomized controlled trial of intravenous N-acetylcysteine.
Rashid ST; Salman M; Myint F; Baker DM; Agarwal S; Sweny P; Hamilton G
J Vasc Surg; 2004 Dec; 40(6):1136-41. PubMed ID: 15622367
[TBL] [Abstract][Full Text] [Related]
16. Comparison of Intravenous and Oral Hydration in the Prevention of Contrast-Induced Acute Kidney Injury in Low-Risk Patients: A Randomized Trial.
Martin-Moreno PL; Varo N; Martínez-Ansó E; Martin-Calvo N; Sayón-Orea C; Bilbao JI; Garcia-Fernandez N
Nephron; 2015; 131(1):51-8. PubMed ID: 26336919
[TBL] [Abstract][Full Text] [Related]
17. Preventive strategies of renal insufficiency in patients with diabetes undergoing intervention or arteriography (the PREVENT Trial).
Lee SW; Kim WJ; Kim YH; Park SW; Park DW; Yun SC; Lee JY; Kang SJ; Lee CW; Lee JH; Choi SW; Seong IW; Suh J; Cho YH; Lee NH; Cheong SS; Yoo SY; Lee BK; Lee SG; Hyon MS; Shin WY; Lee SW; Jang JS; Park SJ
Am J Cardiol; 2011 May; 107(10):1447-52. PubMed ID: 21420063
[TBL] [Abstract][Full Text] [Related]
18. Is treatment with N-acetylcysteine to prevent contrast-induced nephropathy when using bicarbonate hydration out of date?
Heng AE; Cellarier E; Aublet-Cuvelier B; Decalf V; Motreff P; Marcaggi X; Deteix P; Souweine B
Clin Nephrol; 2008 Dec; 70(6):475-84. PubMed ID: 19049703
[TBL] [Abstract][Full Text] [Related]
19. The impact of N-acetylcysteine and ascorbic acid in contrast-induced nephropathy in critical care patients: an open-label randomized controlled study.
Palli E; Makris D; Papanikolaou J; Garoufalis G; Tsilioni I; Zygoulis P; Zakynthinos E
Crit Care; 2017 Oct; 21(1):269. PubMed ID: 29089038
[TBL] [Abstract][Full Text] [Related]
20. Comparison of short-term infusion regimens of N-acetylcysteine plus intravenous fluids, sodium bicarbonate plus intravenous fluids, and intravenous fluids alone for prevention of contrast-induced nephropathy in the emergency department.
Kama A; Yılmaz S; Yaka E; Dervişoğlu E; Doğan NÖ; Erimşah E; Pekdemir M
Acad Emerg Med; 2014 Jun; 21(6):615-22. PubMed ID: 25039544
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
